Effectiveness of agomelatine on anhedonia in depressed patients: an outpatient, open-label, real-world study.

Objective The aim of this real-world study was to evaluate the effect of agomelatine on anhedonia as primary endpoint in outpatients under treatment of major depressive episodes.Methods The study was an open-label, multicenter, 8-week phase IV trial. Two hundred fifty-seven (257) patients were recru... View More